Felzartamab in late ABMR

2024-511764-86-00 Therapeutic exploratory (Phase II) Ongoing, recruiting

Start 7 Sep 2021 · Status Ongoing, recruiting · 2 EU/EEA countries · 2 sites

Overview

Sponsor-declared trial summary

Phase Therapeutic exploratory (Phase II)
Status Ongoing, recruiting
Participants planned 30
Countries 2
Sites 2

late antibody mediated renal transplant rejection

Key facts

Sponsor
Medical University Of Vienna
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Pathological Conditions, Signs and Symptoms [C23]
Trial duration
7 Sep 2021 → ongoing
Decision date (initial)
2024-12-11
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-511764-86-00
EudraCT number
2021-000545-40

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

late antibody mediated renal transplant rejection

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Medical University Of Vienna

Sponsor organisation
Medical University Of Vienna
Address
Spitalgasse 23, Alsergrund Alsergrund
City
Vienna
Postcode
1090
Country
Austria

Scientific contact point

Organisation
Medical University Of Vienna
Contact name
Division of Nephrology and Dialysis, Department of Medicine III

Public contact point

Organisation
Medical University Of Vienna
Contact name
Division of Nephrology and Dialysis, Department of Medicine III

Locations

2 EU/EEA countries · 2 investigational sites

By country

CountryMS statusPlanned subjectsSites
Austria Ongoing, recruiting 20 1
Germany Ongoing, recruiting 10 1
Rest of world 0

Investigational sites

Austria

1 site · Ongoing, recruiting
Medical University Of Vienna
Division of Nephrology and Dialysis, Department of Medicine III, Waehringer Guertel 18-20, Alsergrund, Vienna

Germany

1 site · Ongoing, recruiting
Charite Universitaetsmedizin Berlin KöR
Nephrology, Chariteplatz 1, Mitte, Berlin

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Austria 2021-09-07 2021-10-28
Germany 2024-12-11 2024-12-11

Application history

3 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-10-14 Austria Acceptable
2024-12-06
2024-12-11
2 SUBSTANTIAL MODIFICATION SM-2 2025-01-17 Acceptable 2025-02-28
3 SUBSTANTIAL MODIFICATION SM-3 2025-01-17 Austria Acceptable 2025-04-28